Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Giulia SpagnolUnit of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, 35122 Padua, PD, Italy.ORCID 0000-0003-3525-0571
Sofia BigardiUnit of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, 35122 Padua, PD, Italy.ORCID 0009-0004-6873-5924
Michela ZorziUnit of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, 35122 Padua, PD, Italy.
Matteo MorottiDepartment of Oncology, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), 1005 Lausanne, Switzerland.ORCID 0000-0002-1790-1185
Massimo CarolloDepartment of Diagnostics and Public Health, University of Verona, 37129 Verona, VR, Italy.ORCID 0000-0002-6523-6036
Giulia Micol BruniUnit of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, 35122 Padua, PD, Italy.
Orazio De TommasiUnit of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, 35122 Padua, PD, Italy.
Matteo TamagniniUnit of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, 35122 Padua, PD, Italy.
Livia XhindoliUnit of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, 35122 Padua, PD, Italy.
Marco NoventaUnit of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, 35122 Padua, PD, Italy.
Roberto TozziUnit of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, 35122 Padua, PD, Italy.ORCID 0000-0001-6123-1628
Carlo SaccardiUnit of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, 35122 Padua, PD, Italy.ORCID 0000-0001-7476-997X
Matteo MarchettiUnit of Gynecology and Obstetrics, Department of Women and Children's Health, University of Padua, 35122 Padua, PD, Italy.ORCID 0000-0003-4427-0101
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
chemotherapy response scoreinterval cytoreductive surgeryneoadjuvant chemotherapyovarian cancerperitoneal cancer index
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Δ-Peritoneal Cancer Index (Δ-PCI) to Predict Complete Cytoreduction and Histopathological Response to Neoadjuvant Chemotherapy in Ovarian Cancer. · full record | OpenQuestion